Delivery Order SPE2DB20D2104-SPE2DB24FR95H

Award Date 1/8/24
Potential Completion Date 1/9/24
Potential Value $5.6K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Velphoro 500 mg chewable tablets. The $3,562.98 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,959.99, is a delivery order for the medication Velphoro 500 mg chewable tablets. The contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $7,028.54 firm fixed-price delivery order is for the supply of Velphoro 500 mg chewable tablets, with a period of performance through October 29, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,710.98 firm-fixed-price delivery order covers the supply of Velphoro 500 mg chewable tablets. The contract has a period of performance through March 21, 2023. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award, valued at $1,992.86, is for the delivery of Velphoro 500 mg chewable tablets. The contract has an ultimate completion date of April 7, 2025 and is a Firm Fixed Price Delivery Order. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of Velphoro 500 mg chewable tablets to the U.S. government. The $9,530.03 delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a key customer of Amerisourcebergen for pharmaceutical and medical products. The contract has an ultimate completion date of October 9, 2024 and uses a firm fixed-price pricing structure. This contract award is part of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,807.52, is for the delivery of Velphoro 500 mg chewable tablets. The contract has an ultimate completion date of October 31, 2022 and is a firm-fixed-price delivery order. The contract was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a...
This federal contract award, SPE2DB20D3104|SPE2DB22FV3P8, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,262.78 firm fixed-price delivery order is for the supply of Velphoro 500 mg chewable tablets. AmerisourceBergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical covering a broad range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,822.01, is for the delivery of Velphoro 500 mg chewable tablets. This is a firm-fixed-price delivery order contract with an ultimate completion date of April 9, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,446.71, is for the delivery of Velphoro 500 mg chewable tablets. It is a firm fixed-price delivery order contract with an ultimate completion date of August 30, 2024. The contract is not set aside for any specific business type. Amerisourcebergen has significant Indefinite Delivery Contracts (IDCs) with the...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FR95H
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,641.26 delivery order is for the supply of Velphoro 500 mg chewable tablets.

The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The contract does not have a set-aside designation, indicating it was awarded through full and open competition. AmerisourceBergen's parent company is Cencora, Inc., which also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.

Generated 2/27/25, 11:52 AM